UK market access: the importance of a local value story
Practical insights on how to ensure product adoption in the UK
Health reforms throughout European markets reinforce the call for biopharma companies to engage early with a wide range of stakeholders and provide real world evidence to support a product’s value proposition, and the UK is no different.
In the country’s fluid healthcare environment, with its new clinical commissioning groups (CCGs) and different decision makers, market access activities have never been more important in the launch of a new medicine.
Payers now measure value by the impact on the patient and they are demanding meaningful data that demonstrates real world health outcomes from a new product. But market access starts before product approval and activities should first be initiated during the clinical trial phase.
Gaining early understanding of stakeholder requirements and their impact on product development and market launch can help design a more effective lifecycle strategy, which can result in accelerated product approval at a value-based reimbursement price.
The Webinar “Getting Market Access right in the UK”, was presented by Janice Haigh, Practice Leader, Market Access Europe at Quintiles and Gareth Williams, UK Director, Market Access & Innovation at Quintiles and discussed:
- Global influences driving Market Access and how the European Marketplace is evolving with a focus on current changes across the European major markets
- The UK marketplace is evolving with major structural changes going live in the coming months within the NHS. Get insight on those changes and how they will effect pricing and Market Access
- What are the key success factors in getting Market Access right in the UK
Speaker Biographies:
Janice Haigh is Practice Leader for Market Access, Europe within the Consulting division at Quintiles. In this role she is responsible for leading a team of consultants who undertake payer and pricing research, health economics analysis and value development for clients.
Before joining Quintiles, Janice was the Head of Pricing and Market Access for Astellas Pharma Europe where she was responsible for developing and implementing pricing and market access strategy for new and in-market products, working closely with brand teams and affiliates.
Janice has almost 25 years’ experience in healthcare across Europe and is a Fellow of the Chartered Institute of Marketing. She holds an MSc in Management Science from Imperial College and a BSc in Mathematics from Royal Holloway College, University of London.
Gareth Williams, UK Director, Market Access & Innovation at Quintiles, leading a team of experts dedicated to helping biopharma demonstrate the value of their drug in meeting the health care needs of local populations. He joined Quintiles in 2010 and has more than ten years experience in driving commercial strategy across the product life cycle, working with NHS payers, and adapting the promotional mix to suit local health care priorities.
Download: Quintiles' Overcoming Complexity in European Market Access report
Download: Delivering value on a local level